Ivermectin 1%/Metronidazole 0.75% Topical Cream

The Ivermectin 1%/Metronidazole 0.75% Topical Cream is a compounded medication that combines two potent active ingredients, ivermectin and metronidazole, in a semisolid cream base. This formulation is specifically designed to be dispensed in a pump mechanism, which allows for easy, hygienic, and controlled application directly to the affected skin areas. The pump ensures consistent dosing and minimizes the risk of contamination, which is particularly important for patients with compromised skin integrity.

It works by binding to invertebrate muscle and nerve cells of parasites, causing paralysis and death of the parasites. In the context of rosacea, ivermectin has anti-inflammatory properties and helps reduce the number of inflammatory lesions.

Metronidazole, on the other hand, is an antibiotic and antiprotozoal medication that is used to treat a variety of conditions, including bacterial vaginosis, and certain skin disorders such as rosacea. It is believed to work by entering the bacterial and protozoal cells and interfering with their DNA synthesis, ultimately leading to cell death. In rosacea, metronidazole has been shown to reduce inflammation and the number of pustules and papules.

The combination of ivermectin and metronidazole in a single topical formulation provides a multifaceted approach to the treatment of skin conditions that may benefit from both antiparasitic and antibacterial actions. This can be particularly useful in complex skin conditions where both types of microorganisms may be contributing to the disease state. The cream base is designed to be moisturizing and to allow the active ingredients to be absorbed into the skin where they can exert their therapeutic effects.

This compounded medication is intended for use under the guidance of a healthcare provider and is formulated to meet the specific needs of individual patients. It is important for patients to follow the application instructions provided by their healthcare provider to ensure optimal treatment outcomes. Prescribers considering this formulation for their patients can expect a product that addresses multiple mechanisms of action relevant to the treatment of certain skin conditions.

If you have any questions or require further information about the Ivermectin 1%/Metronidazole 0.75% Topical Cream, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is committed to providing comprehensive support and guidance to both patients and healthcare providers.

The combination of Ivermectin 1% and Metronidazole 0.75% in a topical cream formulation is used primarily for the treatment of certain dermatological conditions. Metronidazole is an antibiotic and antiprotozoal medication that is used to treat bacterial infections, including those affecting the skin, and is also commonly used for the treatment of rosacea.

When using this combination topical cream, it is important to consider potential drug interactions. Although systemic absorption of these agents is low when applied topically, interactions can still occur, particularly with other topical agents or if the skin barrier is compromised. Ivermectin, when used topically, has minimal interactions; however, it is important to avoid concomitant use with other medications that enhance the GABAergic system, such as benzodiazepines or barbiturates, as this could theoretically increase the risk of central nervous system depression if systemic absorption occurs.

Metronidazole, on the other hand, may interact with anticoagulants like warfarin, as it can potentiate their effect and increase the risk of bleeding. Patients should be monitored for signs of bleeding if these medications are used concurrently. Additionally, alcohol should be avoided during treatment and for at least 24 hours after the last application of the cream, as metronidazole can cause a disulfiram-like reaction, resulting in nausea, vomiting, and flushing.

It is also advisable to avoid the use of other topical preparations, especially those containing alcohol or astringents, as they may cause irritation when used with this combination cream. Patients should inform their healthcare provider of all medications they are taking, including over-the-counter drugs and herbal supplements, to avoid potential interactions.

Patients with a known hypersensitivity to either ivermectin or metronidazole should not use this formulation. Caution is also advised when using this cream in patients with severe hepatic impairment, as metronidazole is metabolized by the liver and may accumulate to toxic levels in these individuals.

For any questions or concerns regarding the use of this topical cream or potential drug interactions, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is available to provide you with the necessary information to ensure appropriate treatment.

The Ivermectin 1%/Metronidazole 0.75% Topical Cream is a specially compounded medication that combines two active ingredients, ivermectin and metronidazole, in a semisolid cream base. This formulation is designed to be dispensed from a pump mechanism, which allows for easy, controlled application directly to the affected skin areas. The pump ensures that the medication is dispensed in consistent amounts, promoting uniform application and dosing.

Ivermectin is an antiparasitic agent that works by binding to certain parts of the parasite's nerve and muscle cells, increasing the permeability of the cell membrane to chloride ions. This results in paralysis and death of the parasite. It reduces the inflammatory lesions and erythema associated with the disease by targeting the Demodex mites that are thought to contribute to the condition.

Metronidazole, on the other hand, is an antibiotic and antiprotozoal medication. It is believed to work by entering the bacterial and protozoal cells and interfering with their DNA synthesis, ultimately leading to cell death. It is thought to work through its anti-inflammatory properties and its ability to inhibit reactive oxygen species that contribute to the inflammatory process.

When combined in this topical cream, ivermectin and metronidazole offer a dual approach to treating skin conditions like rosacea. Ivermectin targets the parasitic component, while metronidazole addresses the bacterial aspect and reduces inflammation. This combination can lead to a more comprehensive treatment outcome, improving the appearance of the skin and providing relief from symptoms. The cream base also moisturizes and protects the skin, enhancing the overall therapeutic effect.

It is important for patients and prescribers to understand that this formulation should be used as directed by a healthcare professional. The specific dosing regimen will depend on the individual patient's condition and response to treatment. Consistent use as prescribed is crucial for achieving the best results. If you have any questions or require further information about this formulation and its use in treating skin conditions, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to support you with expert advice and personalized care.

As compounding pharmacists at Bayview Pharmacy, we carefully formulate medications to meet the specific needs of our patients. Ivermectin 1%/Metronidazole 0.75% Topical Cream is primarily indicated for certain dermatological conditions. However, the constituents of this compounded medication have been explored for alternative uses. Ivermectin, a member of the avermectin class of broad-spectrum antiparasitic agents, is known for its efficacy in treating infestations like scabies and head lice, alongside its primary indication for rosacea. Its antiparasitic properties may also demonstrate benefit against demodex mites, which have been implicated in some skin disorders.

Metronidazole, on the other hand, with its antimicrobial and anti-inflammatory activities, is primarily used to treat bacterial vaginosis and rosacea. However, studies have revealed its utility in managing conditions like hidradenitis suppurativa and certain inflammatory bowel diseases when used topically, although these are not standard uses for the combination in our formulation. The anti-inflammatory effects of metronidazole make it potentially useful in a broader range of inflammatory skin disorders beyond its typical use.

This compounded formulation is especially suited for cutaneous application where the dual action of antimicrobial and antiparasitic treatment is desirable. The cream is dispensed in a pump mechanism which offers a convenient and controlled mode of administration, ensuring consistent dosing and minimizing the risk of contamination. When considering off-label uses for this formulation, it is critical to consult a healthcare provider as they can provide the best guidance based on current medical evidence and individual patient circumstances.

Please note that the use of this formulation for conditions other than those for which it is primarily indicated should be based on the discretion of the prescriber and a thorough understanding of the patient's medical history and current health status. We encourage both patients and prescribers to reach out to us at Bayview Pharmacy with any questions or for more detailed information regarding the potential uses and considerations when prescribing or using this Ivermectin 1%/Metronidazole 0.75% Topical Cream. Our team is committed to providing comprehensive support and guidance to support the safe and appropriate medication use.